Ena Respiratory

PharmaceuticalsSeries BMelbourne, Australiaenarespiratory.com

Latest round

Series B

Last raised

Oct 2025

Total raised

$58M

Investors

14

About Ena Respiratory

Founded in 2020 and based in Victoria, Australia, Ena Respiratory Pty Ltd engages in the research and development of solutions for the treatment and prevention of respiratory infections. Dr. Christophe Demaison is leading the firm as CEO as of 2024. The company offers a nasal innate immune regulator to mitigate the consequences of a viral respiratory illness. The company's lead product, INNA-051, is currently in clinical development. This nasal spray is designed to help the innate immune response to respiratory viruses, particularly in high-risk individuals such as those with COPD, asthma, and other comorbidities.

Who invested in Ena Respiratory

14 investors across 3 rounds

See all investors in Ena Respiratory

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 22, 2025

    Amount

    $22M

    Investors

    Locked

  2. Series A

    Feb 4, 2021

    Amount

    $27M

    Investors

    Locked

  3. Series A

    Sep 28, 2020

    Amount

    $8.4M

    Investors

    Locked

Questions about Ena Respiratory

Who invested in Ena Respiratory?

Ena Respiratory has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ena Respiratory raised?

Ena Respiratory has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Ena Respiratory last raise money?

Ena Respiratory's most recent round on record is a Series B, in Oct 2025.

What does Ena Respiratory do?

Founded in 2020 and based in Victoria, Australia, Ena Respiratory Pty Ltd engages in the research and development of solutions for the treatment and prevention of respiratory infections.

Where is Ena Respiratory headquartered?

Ena Respiratory is headquartered in Melbourne, Australia.

Which VCs invest in companies like Ena Respiratory?

Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Movac back pharmaceuticals companies at Ena Respiratory's stage. Their profiles are linked below.

Raising like Ena Respiratory? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.